Ligand profile
ZINC12493817
Virtual-screening candidate from ZINC.
Bound to: KP13_04902 — TonB-dependent siderophore receptor
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC12493817- UniProt (similar protein)
P06971- Tanimoto
- 0.667
- Target protein
- KP13_04902
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 94.8
- −1 ≤ LogP ≤ 5 2.81
- MW ≤ 500 Da 274.4
- LogP ≤ 5 2.81
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 13
- TPSA ≤ 140 Ų 94.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(O)CCCCCCCCCC[C@@H](O)CC(=O)OO=C(O)CCCCCCCCCC[C@@H](O)CC(=O)O
InChI=1S/C14H26O5/c15-12(11-14(18)19)9-7-5-3-1-2-4-6-8-10-13(16)17/h12,15H,1-11H2,(H,16,17)(H,18,19)/t12-/m1/s1InChI=1S/C14H26O5/c15-12(11-14(18)19)9-7-5-3-1-2-4-6-8-10-13(16)17/h12,15H,1-11H2,(H,16,17)(H,18,19)/t12-/m1/s1
CEDZIURHISELSQ-GFCCVEGCSA-NCEDZIURHISELSQ-GFCCVEGCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- FTT
- Homolog
- P06971
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC12493817 →
- ZINC ZINC20 ZINC12493817 →
- UniProt UniProt P06971 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC12493817”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04902.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).